Loading...

Sandy Wong, MD

Title(s)Assistant Professor, Medicine
SchoolSchool of Medicine
Address400 Parnassus Avenue
San Francisco CA 94117
vCardDownload vCard

    Collapse Overview 

    Collapse ORNG Applications 
    Collapse Clinical Trials
    Collapse Websites
    Collapse Twitter

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. CRISPR-based screens uncover determinants of immunotherapy response in multiple myeloma. Blood Adv. 2020 Jul 14; 4(13):2899-2911. Ramkumar P, Abarientos AB, Tian R, Seyler M, Leong JT, Chen M, Choudhry P, Hechler T, Shah N, Wong SW, Martin TG, Wolf JL, Roybal KT, Pahl A, Taunton J, Wiita AP, Kampmann M. PMID: 32589729.
      View in: PubMed   Mentions:    Fields:    
    2. Proteasome inhibitor-induced modulation reveals the spliceosome as a specific therapeutic vulnerability in multiple myeloma. Nat Commun. 2020 Apr 22; 11(1):1931. Huang HH, Ferguson ID, Thornton AM, Bastola P, Lam C, Lin YT, Choudhry P, Mariano MC, Marcoulis MD, Teo CF, Malato J, Phojanakong PJ, Martin TG, Wolf JL, Wong SW, Shah N, Hann B, Brooks AN, Wiita AP. PMID: 32321912.
      View in: PubMed   Mentions:    Fields:    
    3. Impact of Plerixafor Use at Different Peripheral Blood CD34+ Thresholds on Autologous Stem Cell Collection in Patients with Multiple Myeloma. Biol Blood Marrow Transplant. 2020 May; 26(5):876-883. Shah EE, Young RP, Wong SW, Damon LE, Wolf JL, Shah ND, Leavitt AD, Loeffler P, Martin TG. PMID: 31785375.
      View in: PubMed   Mentions: 1     Fields:    
    4. A Single-Center Retrospective Cohort Analysis of Venetoclax in Relapsed/Refractory Multiple Myeloma. Blood. 2019 Nov 13; 134(Supplement_1):5576-5576. Swetha Kambhampati, Derek Galligan, Guy Ledergor, Thomas G. Martin, Jeffrey Wolf, Sandy W. Wong, Nina D. Shah. .
      View in: Publisher Site   Mentions:
    5. Germline Variation Predicts Treatment Response in Multiple Myeloma. Blood. 2019 Nov 13; 134(Supplement_1):4397-4397. Kyle Roter, Donglei Hu, Alyssa Clay-Gilmour, Scott Huntsman, Nina D. Shah, Sandy W. Wong, Thomas G. Martin, Jeffrey Lee Wolf, Moritz Binder, Shaji K. Kumar, S. Vincent Rajkumar, Susan L. Slager, Celine M. Vachon, Elad Ziv. .
      View in: Publisher Site   Mentions:
    6. Profiling the Cell Surface Landscape of Proteasome Inhibitor-Treated and -Resistant Multiple Myeloma to Guide Immunotherapy Targeting, Diagnosis, and Biology. Blood. 2019 Nov 13; 134(Supplement_1):1803-1803. Ian Ferguson, Yu-Hsiu T. Lin, Sami Tuomivaara, Jeffrey L. Wolf, Thomas G. Martin, Sandy W. Wong, Nina D. Shah, Christoph Driessen, Brian G. Van Ness, Arun P. Wiita. .
      View in: Publisher Site   Mentions:
    7. Dynamics of Activated CD8+ T-cells and Decreased Osteoclasts in the Tumor Microenvironment are Associated with Clinical Efficacy of Anti-PD-L1 and Anti-CD38 Combination Treatment in Relapsed or Refractory Multiple Myeloma. Blood. 2019 Nov 13; 134(Supplement_1):1907-1907. Aparna Raval, Hearn Jay Cho, Cherie Green, Elisabeth Wassner Fritsch, Connie Ma, Naomi Chang, Mark Yan, Mark Kockx, Shine Shen, Ling-Yuh Huw, Emily Balestiere, Marina Lipkind, Huang Huang, Michelle Byrtek, Dawn Colburn, Sandy W. Wong, Jeffrey M. Venstrom, Joanne I Adamkewicz. .
      View in: Publisher Site   Mentions:
    8. DNA methyltransferase inhibitors upregulate CD38 protein expression and enhance daratumumab efficacy in multiple myeloma. Leukemia. 2020 Mar; 34(3):938-941. Choudhry P, Mariano MC, Geng H, Martin TG, Wolf JL, Wong SW, Shah N, Wiita AP. PMID: 31595037.
      View in: PubMed   Mentions: 1     Fields:    
    9. A single-center retrospective cohort analysis of venetoclax in relapsed/refractory multiple myeloma. Clinical Lymphoma Myeloma & Leukemia. 2019 Oct 1; 19(10):e261. Swetha Kambhampati, Derek Galligan, Nina Shah, Jeffrey Wolf, Sandy Wong, Thomas Martin. .
      View in: Publisher Site   Mentions:
    10. Single cell Dissection of Resistance to anti-BCMA CAR-T cell Therapy. Clinical Lymphoma Myeloma & Leukemia. 2019 Oct 1; 19(10):e25-e26. Guy Ledergor, Elizabeth McCarthy, Nina Shah, Sandy Wong, Hewitt Chang, Frances Fan, Evans Shao, Lissa Gray, Alexander Cheung, Serena Kwek, Sophia Bylsma, Samuel Del Favero, Rosanna Wustrack, Matthew Spitzer, Jeffrey Wolf, Thomas Martin, Jimmie Ye, Lawrence Fong. .
      View in: Publisher Site   Mentions:
    11. Treatment of Multiple Myeloma: ASCO and CCO Joint Clinical Practice Guideline. J Clin Oncol. 2019 05 10; 37(14):1228-1263. Mikhael J, Ismaila N, Cheung MC, Costello C, Dhodapkar MV, Kumar S, Lacy M, Lipe B, Little RF, Nikonova A, Omel J, Peswani N, Prica A, Raje N, Seth R, Vesole DH, Walker I, Whitley A, Wildes TM, Wong SW, Martin T. PMID: 30932732.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    12. Updates on Hematologic Malignancies in the Older Adult: Focus on Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia, and Multiple Myeloma. Curr Oncol Rep. 2019 03 08; 21(4):35. Huang LW, Wong SW, Andreadis C, Olin RL. PMID: 30848394.
      View in: PubMed   Mentions:    Fields:    
    13. Retrospective Analysis of Modified Hyper-CVAD Therapy Combined with Proteasome Inhibition for Patients with Multiple Myeloma and Renal Insufficiency or Renal Failure. Blood. 2018 Nov 29; 132(Supplement 1):3236-3236. Derek Galligan, Rupa Narayan, Sarah Kim, Ann Lazar, Marisela Tan, Richard Fong, Mimi Lo, Nina Shah, Shagun Arora, Sandy W. Wong, Thomas G. Martin, Jeffrey Lee Wolf. .
      View in: Publisher Site   Mentions:
    14. Daratumumab binds to mobilized CD34+ cells of myeloma patients in vitro without cytotoxicity or impaired progenitor cell growth. Exp Hematol Oncol. 2018; 7:27. Ma X, Wong SW, Zhou P, Chaulagain CP, Doshi P, Klein AK, Sprague K, Kugelmass A, Toskic D, Warner M, Miller KB, Lee L, Varga C, Comenzo RL. PMID: 30356940.
      View in: PubMed   Mentions:
    15. Outcome of Patients With Newly Diagnosed Systemic Light-Chain Amyloidosis Associated With Deletion of 17p. Clin Lymphoma Myeloma Leuk. 2018 11; 18(11):e493-e499. Wong SW, Hegenbart U, Palladini G, Shah GL, Landau HJ, Warner M, Toskic D, Jaccard A, Hansen T, Bladé J, Cibeira MT, Kastritis E, Dispenzieri A, Wechalekar A, Varga C, Schönland SO, Comenzo RL. PMID: 30104177.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    16. Zoledronic acid-induced orbital inflammation in a patient with multiple myeloma. J Oncol Pharm Pract. 2019 Jul; 25(5):1253-1257. Tan M, Kalin-Hajdu E, Narayan R, Wong SW, Martin TG. PMID: 30005587.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    17. Phase I-b study of isatuximab + carfilzomib in relapsed and refractory multiple myeloma (RRMM). Journal of Clinical Oncology. 2018 May 20; 36(15_suppl):8014-8014. Ajai Chari, Joshua Ryan Richter, Nina Shah, Sandy Wai Kuan Wong, Sundar Jagannath, Hearn J. Cho, Noa Biran, Jeffrey Wolf, Samir S. Parekh, Pamela N. Munster, Deepu Madduri, Frank Campana, Thomas G. Martin. .
      View in: Publisher Site   Mentions:
    18. Repurposing tofacitinib as an anti-myeloma therapeutic to reverse growth-promoting effects of the bone marrow microenvironment. Haematologica. 2018 07; 103(7):1218-1228. Lam C, Ferguson ID, Mariano MC, Lin YT, Murnane M, Liu H, Smith GA, Wong SW, Taunton J, Liu JO, Mitsiades CS, Hann BC, Aftab BT, Wiita AP. PMID: 29622655.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimalsCells
    19. 192 Impact of Plerixafor Use at Different Peripheral Blood CD34+ Cell Thresholds on Autologous Stem Cell Collection in Patients with Multiple Myeloma. Biology of Blood and Marrow Transplantation. 2018 Mar 1; 24(3):s176-s177. Eshana E. Shah, Rebecca Young, Sandy W. Wong, Thomas G. Martin. .
      View in: Publisher Site   Mentions:
    20. A Single-Center Retrospective Cohort Analysis of Venetoclax in Relapsed/Refractory Multiple Myeloma. Clinical Lymphoma Myeloma & Leukemia. 2017 Sep 1; 17:s339. Derek Galligan, Nina Shah, Jeffrey Wolf, Sandy Wong, Linda Abramovitz, Brenn Donnelly, Rupa Narayan, Gabriel Mannis, Shagun Arora, Amy Marsala, Miguel Cerejo, Thomas Martin. .
      View in: Publisher Site   Mentions:
    21. Primary Amyloidosis With Renal Involvement: Outcomes in 77 Consecutive Patients at a Single Center. Clin Lymphoma Myeloma Leuk. 2017 11; 17(11):759-766. Wong SW, Toskic D, Warner M, Varga C, Moreno-Koehler A, Fein D, Fogaren T, Lee L, Oliver CM, Guthrie SD, Comenzo RL. PMID: 28689003.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    22. A single-center retrospective cohort analysis of venetoclax in post-transplant, relapsed/refractory multiple myeloma. Journal of Clinical Oncology. 2017 May 20; 35(15_suppl):e19514-e19514. Derek Galligan, Nina Shah, Jeffrey Lee Wolf, Sandy Wai Kuan Wong, Linda Abramovitz, Brenn Donnelly, Rupa Narayan, Gabriel N. Mannis, Shagun D. Arora, Thomas G. Martin. .
      View in: Publisher Site   Mentions:
    23. Stem cell transplantation in patients with systemic AL amyloidosis referred for transplant after suboptimal responses to bortezomib-based initial therapy. Bone Marrow Transplant. 2017 06; 52(6):936-937. Wong SW, Larivee D, Warner M, Sprague KA, Fogaren T, Comenzo RL. PMID: 28394371.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    24. Toxicities, response and survival: Autologous stem cell transplantation for multiple myeloma over 25 years at a single center. Cancer Treatment and Research Communications. 2017; 11:1-5. View Publication.
    25. Toxicities, response and survival: Autologous stem cell transplantation for multiple myeloma over 25 years at a single center. Cancer Treatment and Research Communications. 2017 Jan 1; 11:1-5. Sandy W. Wong, Melissa Warner, Alejandro Moreno-Koehler, Athena Kritharis, Michael E. Coyle, Deborah Black, Valerie Relias, Terry Fogaren, Nancy Cody Lyons, Francois Toka, Denise Larivee, Andrew M. Evens, Grace Kao, Kellie Sprague, Andreas K. Klein, Kenneth B. Miller, Raymond L. Comenzo. .
      View in: Publisher Site   Mentions:
    26. siRNA targeting the ? light chain constant region: preclinical testing of an approach to nonfibrillar and fibrillar light chain deposition diseases. Gene Ther. 2016 10; 23(10):727-733. Ma X, Zhou P, Wong SW, Warner M, Chaulagain C, Comenzo RL. PMID: 27383253.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    27. Beyond the plasma cell: emerging therapies for immunoglobulin light chain amyloidosis. Blood. 2016 05 12; 127(19):2275-80. Weiss BM, Wong SW, Comenzo RL. PMID: 26907632.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    28. CD38 Monoclonal Antibody Therapies for Multiple Myeloma. Clin Lymphoma Myeloma Leuk. 2015 Nov; 15(11):635-45. Wong SW, Comenzo RL. PMID: 26443328.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimals
    29. Pre-clinical translational studies of daratumumab in patients with myeloma or AL amyloidosis undergoing autologous hematopoietic stem cell transplantation (SCT). Journal of Clinical Oncology. 2015 May 20; 33(15_suppl):8587-8587. Chakra Pani Chaulagain, Xun Ma, Parul Doshi, Sandy Wai Kuan Wong, Andreas Kirschmer Klein, Kellie A. Sprague, Ping Zhou, Ray Comenzo. .
      View in: Publisher Site   Mentions:
    30. MUC1 Knockdown With RNA Interference Inhibits Pancreatic Cancer Growth. J Surg Res. 2009 Nov; 157(1):e39-46. Yuan Z, Liu X, Wong S, Machan JT, Chung MA. PMID: 19482310.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimalsCells
    31. Down-regulation of MUC1 in cancer cells inhibits cell migration by promoting E-cadherin/catenin complex formation. Biochem Biophys Res Commun. 2007 Oct 26; 362(3):740-6. Yuan Z, Wong S, Borrelli A, Chung MA. PMID: 17764657.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansCells
    32. A natural mutation in the Tyk2 pseudokinase domain underlies altered susceptibility of B10.Q/J mice to infection and autoimmunity. Proc Natl Acad Sci U S A. 2003 Sep 30; 100(20):11594-9. Shaw MH, Boyartchuk V, Wong S, Karaghiosoff M, Ragimbeau J, Pellegrini S, Muller M, Dietrich WF, Yap GS. PMID: 14500783.
      View in: PubMed   Mentions: 35     Fields:    Translation:Animals
    Sandy's Networks
    Concepts (95)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (20)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _
    ↑